A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...

The FDA approval of Ervebo comes shortly after another Ebola vaccine developed by Johnson & Johnson and Bavarian Nordic, known as Ad26.ZEBOV/MVA-BN-Filo, was filed for approval in Europe.

Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

BRAVECTO QUANTUM exemplifies Merck Animal Health’s commitment to groundbreaking science and has been recognized as a winner of the 2024 Edison Awards and the 2024 S&P Global Awards for Best New ...